Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alfi, Inc. stock logo
ALFIW
Alfi
$0.00
$0.00
$2.88
N/AN/A6,051 shsN/A
Grom Social Enterprises, Inc. stock logo
GROM
Grom Social Enterprises
$0.00
-42.9%
$0.00
$0.00
$0.31
$4K1.61,988 shs295 shs
Kubient, Inc. stock logo
KBNT
Kubient
$0.00
$0.00
$0.00
$0.00
$1K1.053,388 shs26,935 shs
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
$0.00
$0.00
$0.07
$6.39M-0.0611,644 shsN/A
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alfi, Inc. stock logo
ALFIW
Alfi
0.00%0.00%0.00%0.00%0.00%
Grom Social Enterprises, Inc. stock logo
GROM
Grom Social Enterprises
0.00%0.00%-55.56%-55.56%-99.79%
Kubient, Inc. stock logo
KBNT
Kubient
0.00%0.00%0.00%0.00%-50.00%
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
0.00%0.00%+9,900.00%+4,900.00%+9,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alfi, Inc. stock logo
ALFIW
Alfi
N/AN/AN/AN/AN/AN/AN/AN/A
Grom Social Enterprises, Inc. stock logo
GROM
Grom Social Enterprises
0.1908 of 5 stars
0.03.00.00.00.60.00.6
Kubient, Inc. stock logo
KBNT
Kubient
N/AN/AN/AN/AN/AN/AN/AN/A
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alfi, Inc. stock logo
ALFIW
Alfi
0.00
N/AN/AN/A
Grom Social Enterprises, Inc. stock logo
GROM
Grom Social Enterprises
0.00
N/AN/AN/A
Kubient, Inc. stock logo
KBNT
Kubient
0.00
N/AN/AN/A
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alfi, Inc. stock logo
ALFIW
Alfi
$200.68KN/AN/AN/AN/AN/A
Grom Social Enterprises, Inc. stock logo
GROM
Grom Social Enterprises
$3.72M0.00N/AN/A$6.25 per share0.00
Kubient, Inc. stock logo
KBNT
Kubient
$1.17M0.00N/AN/AN/A
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
$1.10M0.00N/AN/AN/ANaN
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alfi, Inc. stock logo
ALFIW
Alfi
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Grom Social Enterprises, Inc. stock logo
GROM
Grom Social Enterprises
-$12.53M-$11.67N/AN/AN/AN/AN/AN/A
Kubient, Inc. stock logo
KBNT
Kubient
-$13.62MN/A0.00N/AN/AN/AN/AN/A
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
N/A-$2.24N/AN/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alfi, Inc. stock logo
ALFIW
Alfi
N/AN/AN/AN/AN/A
Grom Social Enterprises, Inc. stock logo
GROM
Grom Social Enterprises
N/AN/AN/AN/AN/A
Kubient, Inc. stock logo
KBNT
Kubient
N/AN/AN/AN/AN/A
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Alfi, Inc. stock logo
ALFIW
Alfi
N/A
Grom Social Enterprises, Inc. stock logo
GROM
Grom Social Enterprises
15.94%
Kubient, Inc. stock logo
KBNT
Kubient
13.91%
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
81.56%

Insider Ownership

CompanyInsider Ownership
Alfi, Inc. stock logo
ALFIW
Alfi
N/A
Grom Social Enterprises, Inc. stock logo
GROM
Grom Social Enterprises
0.01%
Kubient, Inc. stock logo
KBNT
Kubient
22.33%
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
9.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Alfi, Inc. stock logo
ALFIW
Alfi
40N/AN/ANot Optionable
Grom Social Enterprises, Inc. stock logo
GROM
Grom Social Enterprises
4509.02 million9.02 millionNot Optionable
Kubient, Inc. stock logo
KBNT
Kubient
4014.51 million11.44 millionOptionable
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
8042.62 million38.79 millionNot Optionable

Recent News About These Companies

Kaleido Biosciences Inc (KLDO)
ViCentra wins CE mark for Kaleido insulin pump
Onyx Boox T10C e-Note With Kaleido 3 Display Launched

New MarketBeat Followers Over Time

Media Sentiment Over Time

Alfi stock logo

Alfi NASDAQ:ALFIW

Alfi, Inc. provides interactive intelligent artificial intelligence and machine learning software solutions. Alfi, Inc. was formerly known as Lectrefy, Inc. and changed its name to Alfi, Inc. in January 2020. The company was founded in 2018 and is based in Miami Beach, Florida.

Grom Social Enterprises stock logo

Grom Social Enterprises NASDAQ:GROM

$0.0004 0.00 (-42.86%)
As of 08/15/2025 11:10 AM Eastern

Grom Social Enterprises, Inc., through its subsidiaries, operates as a media, technology, and entertainment company in the United States and Philippines. It operates through three segments: Animation, Original Content, and Social and Technology. The company operates a social media network for children under the age of 13 years. It also produces animated films and televisions series; and provides web filtering services to schools and government agencies, as well as acquires, develops, and builds commercial potential of kids and family entertainment properties and associated business opportunities. Grom Social Enterprises, Inc. was founded in 2012 and is headquartered in Boca Raton, Florida.

Kubient stock logo

Kubient NASDAQ:KBNT

$0.0001 0.00 (0.00%)
As of 08/15/2025 03:07 PM Eastern

Kubient, Inc. develops a cloud-based software platform for digital advertising industry. It develops Audience Marketplace, a platform for real-time trading of digital, programmatic advertising. The company's platform allows advertisers and publishers the ability to use machine learning during programmatic advertising inventory auction. The company was incorporated in 2017 and is based in New York, New York.

Kaleido Biosciences stock logo

Kaleido Biosciences NASDAQ:KLDO

Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the treatment of multi drug resistant infection, chronic kidney disease, atherosclerotic cardiovascular disease, cardio-metabolic syndrome, immuno-oncology, and inflammatory bowel diseases. The company has collaboration agreements with Institute Gustave Roussy, Washington University, and Janssen. Kaleido Biosciences, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts.